DE69529405T2 - Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper - Google Patents

Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper

Info

Publication number
DE69529405T2
DE69529405T2 DE69529405T DE69529405T DE69529405T2 DE 69529405 T2 DE69529405 T2 DE 69529405T2 DE 69529405 T DE69529405 T DE 69529405T DE 69529405 T DE69529405 T DE 69529405T DE 69529405 T2 DE69529405 T2 DE 69529405T2
Authority
DE
Germany
Prior art keywords
monoclonal antibody
thymidine phosphorylase
human
growth factor
cell growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69529405T
Other languages
English (en)
Other versions
DE69529405D1 (en
Inventor
Kazutaka Miyadera
Yuji Yamada
Yuji Takebayashi
Shin-Ichi Akiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of DE69529405D1 publication Critical patent/DE69529405D1/de
Application granted granted Critical
Publication of DE69529405T2 publication Critical patent/DE69529405T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
DE69529405T 1994-12-28 1995-12-25 Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper Expired - Lifetime DE69529405T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32732894A JP3268147B2 (ja) 1994-12-28 1994-12-28 モノクローナル抗体
PCT/JP1995/002661 WO1996020217A1 (fr) 1994-12-28 1995-12-25 Anticorps monoclonal

Publications (2)

Publication Number Publication Date
DE69529405D1 DE69529405D1 (en) 2003-02-20
DE69529405T2 true DE69529405T2 (de) 2003-10-30

Family

ID=18197918

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529405T Expired - Lifetime DE69529405T2 (de) 1994-12-28 1995-12-25 Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper

Country Status (8)

Country Link
US (1) US5798213A (de)
EP (1) EP0749981B1 (de)
JP (1) JP3268147B2 (de)
AT (1) ATE231167T1 (de)
AU (1) AU4315396A (de)
DE (1) DE69529405T2 (de)
ES (1) ES2191722T3 (de)
WO (1) WO1996020217A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1444521A4 (de) * 2001-09-17 2006-12-06 Univ Texas Verfahren und zusammensetzungen unter beteiligung von thymidinphosphorylase als marker für hiv-infektion, den verlauf von aids und arzneistoffresistenz
EP3067698A1 (de) 2015-03-11 2016-09-14 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Pd-ecgf als biomarker für krebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
US5227302A (en) * 1988-12-20 1993-07-13 Ludwig Institute For Cancer Research DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)

Also Published As

Publication number Publication date
WO1996020217A1 (fr) 1996-07-04
JPH08183800A (ja) 1996-07-16
AU4315396A (en) 1996-07-19
ES2191722T3 (es) 2003-09-16
JP3268147B2 (ja) 2002-03-25
EP0749981A4 (de) 2000-03-08
DE69529405D1 (en) 2003-02-20
ATE231167T1 (de) 2003-02-15
US5798213A (en) 1998-08-25
EP0749981B1 (de) 2003-01-15
EP0749981A1 (de) 1996-12-27

Similar Documents

Publication Publication Date Title
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
DE69309906T2 (de) Behandlung für entzündungserkrankung des darmes
ATE159727T1 (de) Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
FI944509A (fi) Interferonireseptorin vastaisia monoklonaalisia vasta-aineita, joilla on neutralisoivaa aktiivisuutta tyypin I interferonia vastaan
ATE501254T1 (de) P- selectin ligandenprotein
DE69104602D1 (de) Stressprotein aus bakterien.
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
DE69216600T2 (de) Synthetisches CDw52(CAMPATH-1) Peptidantigen
DE69529405T2 (de) Pd-ecgf / thymidin phosphorylase spezifischer monoklonaler antikörper
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
AU8751891A (en) A collagen binding protein as well as its preparation
DE69332583T2 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
FR2701955B1 (fr) Facteur de croissance de la famille de l'HARP, procédé d'obtention et applications.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition